AbbVie Baxter Golden Cross: One Signal Proves Real
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesTwo pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
Regulators scrutinize exchange activity amid sanction challenges. This article breaks down CoinEx's denial, the fund ...
BlackRock signals a wallet-first strategy to place traditional stocks and ETFs into regulated digital wallets, aiming...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Paradigm is preparing a $1.5B fund to invest in AI, robotics, and frontier technologies while maintaining crypto inve...
Salesforce posted a solid Q4 with non-GAAP earnings beating estimates, but the stock sank as investors questioned gro...
Alphabet and Amazon are issuing investment-grade debt at scale, drawing funds away from U.S. Treasuries. The shift pl...
When a Planet Labs CEO sells shares, investors take note. This article breaks down what the move could signal, how to...
A single chokepoint can reshape markets. When the strait hormuz closure sent oil prices higher, energy shares jumped ...
U.S. stocks extended a multi-day rally as bullish options flow and leveraged ETF buying push prices higher. Analysts ...
A rising AI startup is inviting accredited investors to join a pre-IPO round at $0.85 per share before a March 12 dea...
As HMBS 2.0 stalls and a 98% buyout rule tightens liquidity, Longbridge Financial’s Tim Wilkinson explains how privat...